Cargando…
The development of polycythemia vera after phlebotomy treatment for hereditary haemochromatosis
Autores principales: | van Bommel, Erik JM, Kelder, Denise, Hoeks, Marlijn PA, Herbers, Alexandra HE |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176116/ https://www.ncbi.nlm.nih.gov/pubmed/35844679 http://dx.doi.org/10.1002/jha2.222 |
Ejemplares similares
-
Indications and use of therapeutic phlebotomy in polycythemia vera: which role for erythrocytapheresis?
por: Teofili, Luciana, et al.
Publicado: (2018) -
Optimized and Personalized Phlebotomy Schedules for Patients Suffering From Polycythemia Vera
por: Lilienthal, Patrick, et al.
Publicado: (2020) -
Different effect of hydroxyurea and phlebotomy on prevention of arterial and venous thrombosis in Polycythemia Vera
por: Barbui, Tiziano, et al.
Publicado: (2018) -
Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera
por: Triguero, Ana, et al.
Publicado: (2022) -
Incidence of solid tumors in polycythemia vera treated with phlebotomy with or without hydroxyurea: ECLAP follow-up data
por: Ghirardi, Arianna, et al.
Publicado: (2018)